{"entity":{"type":"insider","cik":"0001722407","url":"/insider/0001722407","json_url":"/insider/0001722407.json","name":"Temperato John","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":10,"first":"2020-06-15","last":"2022-07-08","span_basis":"filed_date"},"name_variants":[{"name":"Temperato John","source":"filing","n_filings":10,"first_seen":"2020-06-15","last_seen":"2022-07-08"}],"transactions":[{"id":6347565,"accession":"0001551986-22-000070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001551986-22-000070","line_url":"/filing/0001551986-22-000070#line-1","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"9 METERS BIOPHARMA, INC.","issuer_ticker":"NMTR","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001722407","owner_name":"Temperato John","owner_display_name":"Temperato John","owner_url":"/insider/0001722407","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":0.2277,"price_display":"0.23","price_state":"stated","total_value":28462.5,"total_display":"28,462.50","total_whole":"28,463","shares_owned_after":1427522.0,"shares_owned_after_display":"1,427,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-06","filed_date":"2022-07-08","scope":"insider"},{"id":6660274,"accession":"0001578563-22-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578563-22-000017","line_url":"/filing/0001578563-22-000017#line-1","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"9 METERS BIOPHARMA, INC.","issuer_ticker":"NMTR","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001722407","owner_name":"Temperato John","owner_display_name":"Temperato John","owner_url":"/insider/0001722407","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.4457,"price_display":"0.45","price_state":"stated","total_value":22285.0,"total_display":"22,285.00","total_whole":"22,285","shares_owned_after":1302522.0,"shares_owned_after_display":"1,302,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-19","scope":"insider"},{"id":6156146,"accession":"0001551986-22-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001551986-22-000021","line_url":"/filing/0001551986-22-000021#line-1","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"9 METERS BIOPHARMA, INC.","issuer_ticker":"NMTR","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001722407","owner_name":"Temperato John","owner_display_name":"Temperato John","owner_url":"/insider/0001722407","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.5559,"price_display":"0.56","price_state":"stated","total_value":55590.0,"total_display":"55,590.00","total_whole":"55,590","shares_owned_after":1252522.0,"shares_owned_after_display":"1,252,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-04","scope":"insider"},{"id":4898437,"accession":"0001551986-21-000120","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001551986-21-000120","line_url":"/filing/0001551986-21-000120#line-1","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"9 METERS BIOPHARMA, INC.","issuer_ticker":"NMTR","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001722407","owner_name":"Temperato John","owner_display_name":"Temperato John","owner_url":"/insider/0001722407","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.05,"price_display":"1.05","price_state":"stated","total_value":52500.0,"total_display":"52,500.00","total_whole":"52,500","shares_owned_after":1152522.0,"shares_owned_after_display":"1,152,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-19","scope":"insider"},{"id":5105693,"accession":"0001551986-21-000095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001551986-21-000095","line_url":"/filing/0001551986-21-000095#line-1","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"9 METERS BIOPHARMA, INC.","issuer_ticker":"NMTR","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001722407","owner_name":"Temperato John","owner_display_name":"Temperato John","owner_url":"/insider/0001722407","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.05,"price_display":"1.05","price_state":"stated","total_value":26250.0,"total_display":"26,250.00","total_whole":"26,250","shares_owned_after":1102522.0,"shares_owned_after_display":"1,102,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-18","filed_date":"2021-08-19","scope":"insider"},{"id":5153570,"accession":"0001551986-21-000047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001551986-21-000047","line_url":"/filing/0001551986-21-000047#line-1","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"9 METERS BIOPHARMA, INC.","issuer_ticker":"NMTR","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001722407","owner_name":"Temperato John","owner_display_name":"Temperato John","owner_url":"/insider/0001722407","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":100000.0,"total_display":"100,000.00","total_whole":"100,000","shares_owned_after":1077522.0,"shares_owned_after_display":"1,077,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-06","scope":"insider"},{"id":3149704,"accession":"0001551986-20-000331","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001551986-20-000331","line_url":"/filing/0001551986-20-000331#line-1","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"9 METERS BIOPHARMA, INC.","issuer_ticker":"NMTR","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001722407","owner_name":"Temperato John","owner_display_name":"Temperato John","owner_url":"/insider/0001722407","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":153846.0,"shares_display":"153,846","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":99999.9,"total_display":"99,999.90","total_whole":"100,000","shares_owned_after":977522.0,"shares_owned_after_display":"977,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-17","scope":"insider"},{"id":3104318,"accession":"0001551986-20-000259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001551986-20-000259","line_url":"/filing/0001551986-20-000259#line-1","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"9 METERS BIOPHARMA, INC.","issuer_ticker":"NMTR","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001722407","owner_name":"Temperato John","owner_display_name":"Temperato John","owner_url":"/insider/0001722407","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70000.0,"shares_display":"70,000","price_per_share":0.69,"price_display":"0.69","price_state":"stated","total_value":48300.0,"total_display":"48,300.00","total_whole":"48,300","shares_owned_after":615496.0,"shares_owned_after_display":"615,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-21","filed_date":"2020-08-24","scope":"insider"},{"id":2848277,"accession":"0001551986-20-000251","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001551986-20-000251","line_url":"/filing/0001551986-20-000251#line-1","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"9 METERS BIOPHARMA, INC.","issuer_ticker":"NMTR","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001722407","owner_name":"Temperato John","owner_display_name":"Temperato John","owner_url":"/insider/0001722407","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":0.5666,"price_display":"0.57","price_state":"stated","total_value":19831.0,"total_display":"19,831.00","total_whole":"19,831","shares_owned_after":545496.0,"shares_owned_after_display":"545,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-17","scope":"insider"},{"id":3304544,"accession":"0001551986-20-000172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001551986-20-000172","line_url":"/filing/0001551986-20-000172#line-1","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"9 METERS BIOPHARMA, INC.","issuer_ticker":"NMTR","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001722407","owner_name":"Temperato John","owner_display_name":"Temperato John","owner_url":"/insider/0001722407","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.5971,"price_display":"0.60","price_state":"stated","total_value":5971.0,"total_display":"5,971.00","total_whole":"5,971","shares_owned_after":49441.0,"shares_owned_after_display":"49,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2020-06-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001551986","name":"9 METERS BIOPHARMA, INC.","url":"/issuer/0001551986","role":"Director, Officer (Chief Executive Officer)","n_filings":10,"first_seen":"2020-06-15","last_seen":"2022-07-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001722407","retrieved_at":"2026-08-26T10:50:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}